We surveyed 1,000+ patients to uncover their perspectives about direct‑to‑patient. Read the report
Resource Hub
Insights to Move Your Access Strategy Forward
A curated library of research, thought leadership, and expert perspectives for pharma manufacturers that want to drive best-in-class results.
Featured Resources
Explore topics
press
Evolved Health and PHIL Announce Novel Dermatology Program for New Day™ Direct-to-Patient
Readpress
Compliance-By-Design: The Critical Layer for Pharma's Direct-to-Patient Play
Readpress
Protecting Gross-to-Net Performance Through Single-Channel Ecosystems
Readreport
Building Direct-to-Patient Programs that Exceed Today's Patient Expectations
Downloadpress
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program
Readreport
Bridging the Gap to Better Patient Outcomes: What HCPs Want from Pharma's Digital Access Channels
Downloadwebinar
Capturing Actionable Metrics to Improve Patient & Brand Outcomes
Watchpress
The Hidden GTN Drain: Why Specialty-Lite Brands Need To Streamline The PA Process
Readpress
Sprout Pharmaceuticals and PHIL Expand Their Affordable Direct-to-Patient Access Program for Addyi
ReadShowing 1–9 of 104 resources
In the News
PHIL in the Press
Press Release
Evolved Health and PHIL Announce Novel Dermatology Program for New Day™ Direct-to-Patient
Read featureDigital Medicine Society
PHIL is Rewriting the Rules of Direct-to-Patient
Read featurePharmaceutical Commerce
Compliance-By-Design: The Critical Layer for Pharma's Direct-to-Patient Play
Read featureDrug Channels
Protecting Gross-to-Net Performance Through Single-Channel Ecosystems
Read featurePress Release
PHIL Invests in State-of-the-Art Cash Dispense Capabilities, Expanding Direct-to-Patient Fulfillment for Pharma
Read featurePress Release
Tenpoint Therapeutics Ltd and PHIL Partner to Launch YUVEZZI™ Direct-to-Patient Cash Program
Read featurePress Release
Sprout Pharmaceuticals and PHIL Expand Their Affordable Direct-to-Patient Access Program for Addyi
Read featureFierce Pharma
The Hidden GTN Drain: Why Specialty-Lite Brands Need To Streamline The PA Process
Read featureLife Science Leader
Pharma Direct-To-Patient 2.0: From Experiment To Imperative
Read featureDrug Channels
Harnessing the Power of Comprehensive Data to Drive GTN
Read featureBiopharma Dive
Redefining Commercial Success in Specialty-Lite
Read featureBiopharma Dive
Bridging Data Gaps that Impact Retail and Specialty-Lite Success
Read featurePress Release
PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in Pharma
Read featurePress Release
Phil Secures $60 Million Growth Capital Facility from K2 HealthVentures to Accelerate AI Integration
Read featurePress Release
Phil Inc. Adds Duchesnay USA’s Women’s Healthcare Product to Its Patient Access Platform
Read featureReady to simplify medication access?
See how PHIL moves more patients to therapy, quickly and affordably
Take a tour of the PHIL platform and discover how we can help amplify starts, adherence, coverage, and commercial success.
